Skip to content

Clinical trials

Completed Hepatitis C, Chronic trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C, Chronic Status: Completed Country / region: Australia Clear all

52 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20043
20051
20061
20074
20085
20092
20103
20118
20129
20133
20141
20151
20162
20172
20181
20192
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche11
Kirby Institute9
Gilead Sciences7
AbbVie3
Boehringer Ingelheim3
Debiopharm International SA3
GlaxoSmithKline3
Human Genome Sciences Inc.3
AbbVie (prior sponsor, Abbott)1
Bausch Health Americas, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C, Chronic52
Hepatitis C23
Hepatitis3
Acquired Immunodeficiency Syndrome1
Fibrosis1
Hepatitis, Chronic1
Reinfection1

Trials

Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.